Patents by Inventor Brian Jay FELDMAN

Brian Jay FELDMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATION OF MUSCLE AND ADIPOCYTE DISTRIBUTION AND FATE
    Publication number: 20180140684
    Abstract: Modulation of the ADAMTS1 signaling pathway alters the commitment of progenitor cells to a muscle fate; and increases muscle mass.
    Type: Application
    Filed: January 10, 2018
    Publication date: May 24, 2018
    Inventor: Brian Jay Feldman
  • Modulation of muscle and adipocyte distribution and fate
    Patent number: 9950043
    Abstract: Modulation of the ADAMTS1 signaling pathway alters the commitment of progenitor cells to a muscle fate; and increases muscle mass.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: April 24, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventor: Brian Jay Feldman
  • MODULATION OF MUSCLE AND ADIPOCYTE DISTRIBUTION AND FATE
    Publication number: 20160287682
    Abstract: Modulation of the ADAMTS1 signaling pathway alters the commitment of progenitor cells to a muscle fate; and increases muscle mass.
    Type: Application
    Filed: November 15, 2013
    Publication date: October 6, 2016
    Inventor: Brian Jay Feldman
  • Method of screening for an agent that enhances beige fat adipogenesis
    Patent number: 9423404
    Abstract: Methods and compositions are provided for enhancing beige fat adipogenesis, and screening for agents having this activity An adipocyte progenitor cell is contacted with an effective dose of an antagonist of unliganded vitamin D receptor (VDR) activity. The contacting may be performed under adipogenic conditions.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: August 23, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior Unviversity
    Inventor: Brian Jay Feldman
  • PLASMONIC SUBSTRATE FOR MULTIPLEX ASSESSMENT OF TYPE 1 DIABETES
    Publication number: 20160025744
    Abstract: Disclosed are methods and materials providing fluorescence detection of autoantibodies present in individuals who have developed or are at risk for type 1 diabetes. Provided is a plasmonic chip capable of fluorescence-enhancement of >100-fold. The fluorescent signal is generated by an anti-human antibody antibody, such as an anti-IgG antibody that is coupled to a fluorophore selected to emit at a wavelength enhanced by the plasmonic chip, for example in the NIR.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Brian Jay FELDMAN, Hongjie DAI, Rajiv B. KUMAR, Bo ZHANG